EPAS1/HIF-2α: a key regulator for chronic hypoxia across species.
EPAS1/HIF-2α: a key regulator for chronic hypoxia across species.
复制标题
DOI:
10.1113/jp283554
复制
发表时间:
2022-09
影响因子:
5.5
通讯作者:
Moya, Esteban A.
中科院分区:
文献类型:
--
作者:
Moya, Esteban A.
Individuals exposed to hypoxia for brief or long periods of time manifest physiological changes that aim to maintain oxygen homeostasis. For example, acute exposure to hypoxia produces hypoxic ventilatory response (HVR) due to activation of the peripheral chemoreceptors of the carotid body, as well as hypoxia-triggered changes in heart rate. Exposure to extended periods of hypoxia (chronic sustained hypoxia) results in different responses, including a secondary increase in ventilation termed ventilatory acclimatization to hypoxia (VAH), enlargement of carotid bodies, and increased hemoglobin concentration.Experiments involving rodent models and human genetic studies describe the importance of the EPAS1/HIF-2α pathway as one of the main triggers of these hypoxia-induced consequences (Yu et al. 2022; Hodson et al. 2016), supporting the idea that the EPAS1/HIF-2α pathway is crucial for mechanisms of hypoxia adaptation. For instance, pharmacological inhibition of HIF-2α and experiments performed in knockout mice show that disruption of HIF-2α results in a blunted VAH after days of exposure to hypoxia. Studies of human populations living at high altitude demonstrate that genes involved in the EPAS1/HIF-2α pathway show signs of selection and are associated with relatively lower levels of hemoglobin at high altitude, ie, similar to individuals at sea level but lower when compared to other high-altitude populations such as Andeans. And also, Tibetans at highaltitude show increased ventilation when compared to Andean high-altitude populations. In many cases, the potential adaptive or maladaptive roles of these hypoxia-induced changes remain unknown and many groups are enthusiastically applying novel approaches to answer these questions.